Hanmi registered novel process patent for Paclitaxel in Japan.

Published: 2002-05-20 06:56:00

Updated: 2002-05-20 06:56:00

Hanmi pharmaceutical company announced on May 15 that a novel process patent for Paclitaxel, an anti-cancer drug, had been successfully registered in Japan, claiming that this process showed far higher yield with purity under a mild manufacturing condition compared to the existing process.

Hanmi said "about 100grams of bulk was produced with this patented process, and it will be used for Ora...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.